2021 STA Board of Directors - Election Voting

President-Elect (Vote for One of Two)

​​Lara Brewer, PhD

Lara Brewer, a Research Assistant Professor in Anesthesiology and Biomedical Engineering at the University of Utah, has been an enthusiastic STA society supporter since 2003. In addition to regularly mentoring STA research presentations, she previously served on the Board as Director At-Large and was a Co-Chair for the 2018 Annual STA Meeting. She was also a Judge for “Swimming with the Sharks”, a joint STA/FAER entrepreneurial workshop program in 2018, and is an ad-hoc reviewer for several journals.


In collaboration with several major medical device manufacturers, Dr. Brewer’s academic research work has influenced clinical decision support and improved non-invasive patient monitoring devices for anesthesia and critical care. Her graduate and post-doc work in the anesthesiology bioengineering laboratory at the University of Utah centered on non-invasive cardiopulmonary monitoring. Her current primary research interest relates to detection and prevention of opioid-induced respiratory depression. She is an inventor on 14 US and international patents and has diverse clinical research experience at the interesting intersection of patient care, engineering constraints, and business opportunity.


Dr. Brewer values STA’s commitment to open dialogue and collaboration among clinicians, engineers and medical device manufacturers. She believes the thought leading STA community will continue to bring unique foresight, insight and technology solutions for patient care needs. She plans to leverage the unique strengths of the STA membership to develop guidance statements and technology innovation related to our current global pandemic.


Dr. Brewer will foster STA’s mission to promote the application of technology through education, research, and collaboration with industry. She plans to strengthen recruitment, support, and mentoring opportunities for junior members of STA. With continued focus on ample time for meaningful dialogue and a forum for research discussions and brainstorming, Dr. Brewer believes STA will thrive, regardless of our ability to meet in person in 2021.


Jonathan Wanderer, MD, MPhil, FASA

Dr. Jonathan Wanderer is an Associate Professor for Biomedical Informatics and Anesthesiology at Vanderbilt University, where he is the Medical Director for Perioperative Informatics, Associate Fellowship Director for the Clinical Informatics Fellowship Program, and co-course director for the Foundations of Clinical Informatics in the Masters of Applied Clinical Informatics Program. He has been a member of the Society for Technology in Anesthesia since 2012, served as Annual Meeting Chair in 2017, and is currently a member of the Board. He has served on the Anesthesia Quality Institute’s Data Definitions, Data Use and Registry Operations Committees. Additionally, he is a member on Epic’s Anesthesiology Specialty Steering Board and leads Vanderbilt’s Physician Builder program. He enjoys all things related to electronic health records, clinical decision support and data science, and in his downtime, he is attempting to raise twins. 

At Large International Director (Vote for One of Two)

Matthias Gorges, PhD

Dr. Matthias Gorges received his MSc in Biomedical Engineering from the Hamburg University of Applied Sciences, Germany (2005) and his PhD in Bioengineering from the University of Utah, Salt Lake City, USA (2010). After postdoctoral training in Electrical and Computer Engineering at the University of British Columbia, Vancouver, Canada, he became an Assistant Professor in the Department of Anesthesiology, Pharmacology & Therapeutics at UBC in 2016. He is a Scientist at the BC Children’s Hospital Research Institute, where he co-founded the Digital Health Innovation Lab and co-leads the Clinical & Community Data, Analytics & Informatics group. His interdisciplinary research team focusing on the development and application of new technologies in anesthesia and intensive care with an emphasis on digital health and predictive analytics.


Dr. Görges has attended every STA Annual Meeting since 2010, which he enjoys for opportunities to network, discuss new research ideas, and receive feedback from leaders in both engineering and perioperative medicine. He is the current At-Large International Director, and is an Annual Meeting Co-Chair for the 2021 STA Virtual Annual Meeting. Dr. Görges is looking forward to seeing everyone again in person for the 2022 STA Annual Meeting and would be honored to continue to serve on the STA Board for 2021.


​Clyde Matava, MD

Dr. Clyde Matava is a Staff Anesthesiologist at SickKids and Associate Professor at the University of Toronto. He is the Associate Chief, Bioinformatics for Perioperative Services and the Director of Informatics, Innovation and Technology in the Department of Anesthesia at SickKids. Dr. Matava is a member of the SickKids Enterprise Security team, Health Information Management Committee, Clinical Decision Support, Enterprise Hardware team, and MyChart Committee. He led the extraordinarily successful Epic Anesthesia implementation and sits on Epic’s Specialty Steering Board, having developed new features which have been incorporated into Epic’s foundation system.


Dr. Matava has created and designed several apps, and he has won several teaching and innovation awards. His current work focuses on the use of 3D printing, Virtual Reality, and machine learning to improve outcomes in medical education and patient care. He is also co-director of the SickKids’s and University of Toronto’s VR lab - CHISIL that is researching the use of virtual, augmented and mixed reality in medicine. His clinical interests include airway management and regional anesthesia. He is currently President of the Canadian Pediatric Anesthesia Society.


Dr. Matava has been a proud and active member of STA. He has presented at the conference on several occasions. He has mentored residents and fellows with scientific presentations at the STA as well as leading several STA Engineering Challenge teams. Dr. Matava was honored to serve as the 2019 Abstract Co-Chair for the STA Annual Meeting and the 2020 Co-Chair for the STA annual Meeting.

At Large Industry Director (Vote for One of Three)

Justin Adams, BSEE, MBA

Justin Adams is the Chief Executive Officer of AlertWatch, Inc. He has overseen all facets of the firm, including the commercialization of AlertWatch:OR and AlertWatch:OB; having received three FDA 510(k)-clearances for these real-time patient monitoring solutions. Justin co-authored two design patents involving the innovative AlertWatch display, and he continues to code in Objective-C and Swift for fun.


Prior to joining AlertWatch, Justin worked in the automotive industry, investment banking, venture capital, and ran several firms as interim CEO, helping oversee R&D efforts and operational turnarounds. He holds a Bachelor of Science in Electrical Engineering from the University of Michigan, and an MBA from the Ross School of Business.


Justin has enjoyed collaborating on the STA Board over the last year, and he looks forward to helping STA carry out a successful Virtual Annual Meeting in early 2021. He will focus on strengthening STA's role as the premiere organization supporting anesthesia’s critical role in healthcare innovation.


Scott Augustine, MD

Dr. Scott Augustine founded Augustine Medical, Inc. (now known as Arizant/3M, Inc.) in 1987 and served as its CEO, Chairman and Chief Technology Officer until he left the company at the end of 2002. While at Augustine Medical, Dr. Augustine and his team successfully developed several new medical devices, including Bair Huggerâ, the market leading patient temperature management product worldwide; Rangerâ, the market leading patient fluid warming product in the US; Bair Paws®, the market leading heated patient gown; and WarmUp®, a uniquely effective chronic wound therapy. Dr. Augustine is the primary inventor on more than 200 issued US patents.


Dr. Augustine earned his MD degree at the University of Minnesota and was trained in anesthesiology in the US Navy. Dr. Augustine also did Fellowship training in Intensive Care Medicine at Stanford University and Cardiac Anesthesiology at the Mayo Clinic.  He was a staff anesthesiologist at the Research Medical Center in Kansas City, MO and the University of Minnesota in Minneapolis, MN.  He has been a member of the ASA since 1984.


Dr. Augustine was named the 2002 Ernst and Young Entrepreneur of the Year in the Medical Technology and Life Sciences category.  In 2002, Inc. magazine ranked Augustine Medical as the “most innovative small company in America.”  (They define “small” as less than $100 million in revenues.)  In 2002, MIT’s Technology Review ranked Augustine Medical as the most innovative medical device company in the world. Dr. Augustine received the “2011 Outstanding Achievement Award for Alumni,” from his alma mater, the University of Minnesota.


The son of missionary parents, Dr. Augustine spent 7 years of his childhood living in the bush of Tanzania, East Africa.  He has maintained an interest in Africa, its people and its problems.  In 2000, he and his wife started Peace House Africa (PHA), a non-profit dedicated to caring for and educating the orphan children left behind from the AIDS pandemic in Africa.  In 2006, PHA built Peace House Secondary School–a 650 student boarding school for the orphans, outside of Arusha, Tanzania.


​Trent Bryson, MD

Dr. Trent Bryson is an Associate Professor in the Department of Anesthesiology and Pain Management at The University of Texas Southwestern (UTSW) in Dallas, Texas. There he has served as Deputy Chief Information Officer since 2015, assisting in many EHR implementations and upgrades along with pushing UTSW to the leading edge of anesthesia technology adoption. A recent project of note included the development of a novel bar-coding system to integrate on-the-fly printed syringe labels that are recognized by the EHR and used for intraoperative bar-coded medication administration on syringes of all sizes. Dr. Bryson also spearheaded the largest integration of intraoperative infusion pump data capture among all American Epic EHR customers.  In addition, he has worked closely for several years with EHR developers to assist directly in clinician led development cycles of monitoring, transition of care communication, and controlled substance chain of custody modules. His physician-first approach to EHR process has helped reduce the need for documentation clarification for professional billing from over 25% down to less than 2%.